全文获取类型
收费全文 | 25619篇 |
免费 | 1642篇 |
国内免费 | 92篇 |
专业分类
耳鼻咽喉 | 198篇 |
儿科学 | 855篇 |
妇产科学 | 579篇 |
基础医学 | 3418篇 |
口腔科学 | 779篇 |
临床医学 | 2480篇 |
内科学 | 5974篇 |
皮肤病学 | 576篇 |
神经病学 | 2168篇 |
特种医学 | 532篇 |
外科学 | 3191篇 |
综合类 | 208篇 |
一般理论 | 14篇 |
预防医学 | 2179篇 |
眼科学 | 851篇 |
药学 | 1499篇 |
中国医学 | 82篇 |
肿瘤学 | 1770篇 |
出版年
2023年 | 176篇 |
2022年 | 253篇 |
2021年 | 802篇 |
2020年 | 465篇 |
2019年 | 660篇 |
2018年 | 771篇 |
2017年 | 515篇 |
2016年 | 531篇 |
2015年 | 720篇 |
2014年 | 877篇 |
2013年 | 1247篇 |
2012年 | 1875篇 |
2011年 | 2060篇 |
2010年 | 1102篇 |
2009年 | 1043篇 |
2008年 | 1795篇 |
2007年 | 1867篇 |
2006年 | 1812篇 |
2005年 | 1670篇 |
2004年 | 1450篇 |
2003年 | 1338篇 |
2002年 | 1309篇 |
2001年 | 208篇 |
2000年 | 147篇 |
1999年 | 207篇 |
1998年 | 234篇 |
1997年 | 182篇 |
1996年 | 163篇 |
1995年 | 144篇 |
1994年 | 156篇 |
1993年 | 123篇 |
1992年 | 80篇 |
1991年 | 88篇 |
1990年 | 61篇 |
1989年 | 61篇 |
1988年 | 58篇 |
1987年 | 61篇 |
1986年 | 55篇 |
1985年 | 59篇 |
1984年 | 77篇 |
1983年 | 66篇 |
1982年 | 77篇 |
1981年 | 92篇 |
1980年 | 66篇 |
1979年 | 51篇 |
1978年 | 60篇 |
1977年 | 43篇 |
1976年 | 44篇 |
1975年 | 34篇 |
1974年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Features of biliary obstruction were seen in 57 of 300 cases of post-necrotic cirrhosis but gave rise to real diagnostic difficulty in only 11 cases. The paper deals with the recognition and possible pathogenesis of this syndrome. 相似文献
992.
Allen NE Key TJ Dossus L Rinaldi S Cust A Lukanova A Peeters PH Onland-Moret NC Lahmann PH Berrino F Panico S Larrañaga N Pera G Tormo MJ Sánchez MJ Ramón Quirós J Ardanaz E Tjønneland A Olsen A Chang-Claude J Linseisen J Schulz M Boeing H Lundin E Palli D Overvad K Clavel-Chapelon F Boutron-Ruault MC Bingham S Khaw KT Bueno-de-Mesquita HB Trichopoulou A Trichopoulos D Naska A Tumino R Riboli E Kaaks R 《Endocrine-related cancer》2008,15(2):485-497
Epidemiological data show that reproductive and hormonal factors are involved in the etiology of endometrial cancer, but there is little data on the association with endogenous sex hormone levels. We analyzed the association between prediagnostic serum concentrations of sex steroids and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition using a nested case-control design of 247 incident endometrial cancer cases and 481 controls, matched on center, menopausal status, age, variables relating to blood collection, and, for premenopausal women, phase of menstrual cycle. Using conditional regression analysis, endometrial cancer risk among postmenopausal women was positively associated with increasing levels of total testosterone, free testosterone, estrone, total estradiol, and free estradiol. The odds ratios (ORs) for the highest versus lowest tertile were 2.66 (95% confidence interval (CI) 1.50-4.72; P=0.002 for a continuous linear trend) for estrone, 2.07 (95% CI 1.20-3.60; P=0.001) for estradiol, and 1.66 (95% CI 0.98-2.82; P=0.001) for free estradiol. For total and free testosterone, ORs for the highest versus lowest tertile were 1.44 (95% CI 0.88-2.36; P=0.05) and 2.05 (95% CI 1.23-3.42; P=0.005) respectively. Androstenedione and dehydroepiandrosterone sulfate were not associated with risk. Sex hormone-binding globulin was significantly inversely associated with risk (OR for the highest versus lowest tertile was 0.57, 95% CI 0.34-0.95; P=0.004). In premenopausal women, serum sex hormone concentrations were not clearly associated with endometrial cancer risk, but numbers were too small to draw firm conclusions. In conclusion, relatively high blood concentrations of estrogens and free testosterone are associated with an increased endometrial cancer risk in postmenopausal women. 相似文献
993.
994.
ERbeta1 and the ERbeta2 splice variant (ERbetacx/beta2) are expressed in distinct cell populations in the adult human testis 总被引:5,自引:0,他引:5
Saunders PT Millar MR Macpherson S Irvine DS Groome NP Evans LR Sharpe RM Scobie GA 《The Journal of clinical endocrinology and metabolism》2002,87(6):2706-2715
Estrogens can regulate germ cell function. Estrogen action is mediated via high affinity ERs; two subtypes (ERalpha and ERbeta) have been identified. We have shown previously that ERbeta is expressed in nuclei of multiple human testicular cells. A variant isoform of human (h) ERbeta (hERbetacx/2), formed by alternative splicing, has been identified in testicular cDNA libraries by two laboratories. The present study examined the expression of wild-type (ERbeta1) and variant (ERbeta2) beta receptors in human testes by 1) RT-PCR with isoform specific primers, and 2) single and double immunohistochemistry using monoclonal antibodies raised against peptides unique to the C termini of hERbeta1 and hERbeta2. PCR products specific for ERbeta1 and ERbeta2 were amplified from cDNA pools prepared from human testes and granulosa cells. On Western blots, the anti-ERbeta1 monoclonal antibody bound to recombinant ERbeta1 and the anti-ERbeta2 monoclonal to recombinant hERbeta2. Neither bound to the other ERbeta isoform nor to recombinant ERalpha. ERbeta1 and ERbeta2 proteins were both detected in human testis. Immunoexpression of ERbeta1 was most intense in pachytene spermatocytes and round spermatids, whereas low levels of expression were detected in Sertoli cells, spermatogonia, preleptotene, leptotene, zygotene, and diplotene spermatocytes. Highest levels of expression of ERbeta2 protein were detected in Sertoli cells and spermatogonia with low/variable expression in preleptotene, pachytene, and diplotene spermatocytes. No immunostaining was detected in elongating spermatids. Most interstitial cells expressed more ERbeta2 than ERbeta1. It is speculated that the cells most susceptible to modulation by estrogenic ligands are round spermatids in which levels of expression of ERbeta1 are high. In contrast, expression of ERbeta2, an isoform that may act as a dominant negative inhibitor of ER action, in Sertoli cells and spermatogonia, could protect these cells from adverse effects of estrogens. 相似文献
995.
Aitziber Aguinaga Jorge Díaz-González Alejandra Pérez-García Laura Barrado Iván Martínez-Baz Itziar Casado Regina Juanbeltz Carmen Ezpeleta Jesús Castilla 《Enfermedades infecciosas y microbiología clínica》2018,36(6):325-331
Objective
To estimate the prevalence of hepatitis C virus (HCV) infection in Navarra, Spain, as well as to distinguish between diagnosed and undiagnosed infections.Methods
A study was conducted on patients scheduled for surgery unrelated to HCV infection. They were all tested for HCV antibodies, under a routine scheme, from January 2014 to September 2016. Patients with a positive result by enzyme immunoassay were confirmed using immunoblot and/or HCV-RNA. Previous laboratory results were also taken into account. The prevalence was adjusted to the sex and age structure of the Navarra population.Results
The study included a total of 7,378 patients with a median age 46 years, of whom 50% women. HCV antibodies were detected in 69 patients, which is a prevalence in the population of 0.83% (95% confidence interval: 0.64-1.05), and was higher in men (1.11%) than in women (0.56%; P = .0102). Among the HCV positive patients, 67 (97%) had had another previous positive result. Population prevalence of previous positive HCV was 0.80%, and was 0.03% for a new diagnosis. Of the HCV positive patients, 78% had detectable HCV-RNA. It was estimated that 0.65% of the population had had detectable HCV-RNA, and 0.51% continued to have it when recruited into the study.Conclusion
Previous estimates of prevalence of HCV infection should be revised downwards. Only a small proportion of HCV positive patients remain undiagnosed, and only a small part have active infection. 相似文献996.
Orsolic N Giles FJ Gourdeau H Golemovic M Beran M Cortes J Freireich EJ Kantarjian H Verstovsek S 《British journal of haematology》2004,124(6):727-738
The in vitro and in vivo activity of a deoxycytidine analogue, troxacitabine, alone or in combination with imatinib mesylate (IM), was evaluated against human chronic myeloid leukaemia (CML) cell lines both sensitive (KBM5 and KBM7) and resistant (KBM5-R and KBM7-R) to IM. These cell lines differ in their sensitivity to IM but all showed similar sensitivity to treatment with troxacitabine (IC50 = 0.5-1 micromol/l). Combined treatment with troxacitabine and IM revealed additive or synergistic effects. Greater apoptotic response was seen with combined treatment than with either agent alone in KBM7-R cells. In clonogenic assays, troxacitabine showed activity against mononuclear cells from CML patients (IC50 = 0.01 micromol/l) with either IM-sensitive or resistant disease. In vivo efficacy studies were carried out in severe combined immunodeficient mice bearing KBM5 or KBM5-R cells. Troxacitabine was administered i.p. daily for 5 d starting on day 20, at doses of 5, 10, 20, or 25 mg/kg. IM was administered i.p. twice a day for 10 d at a dose of 50 mg/kg starting on day 25. In this setting of late stage disease, troxacitabine led to a significant increase in life span, while IM did not. When IM was combined with troxacitabine at 10 and 25 mg/kg in the KBM5 xenograft model, a further increase in life span was observed and some mice achieved long-term survival. These data indicate that the combination of troxacitabine and IM has significant preclinical activity in advanced CML and that clinical evaluation of this combination is warranted. 相似文献
997.
Hernán Trimarchi Gabriel Casas Rosana Jordan Jorge Martínez Juan Schropp Emilio Ar Freixas Ernesto Efrón 《Transplant infectious disease》2001,3(1):47-50
Abstract: Cytomegalovirus (CMV) is the most important viral agent in kidney transplantation. Clinical manifestations of CMV disease in transplantation include hepatitis, pneumonitis, pancreatitis, kidney allograft dysfunction, colitis, and meningoencephalitis. However, skin involvement is rare. We describe a severely compromised cadaveric‐kidney transplant recipient who developed renal failure, colonic ulcers, and a maculopapular rash accompanied by fever and malaise 4 months after transplantation. Only the skin biopsy was diagnostic and consistent with CMV disease. Intravenous ganciclovir administration resulted in clinical improvement of CMV‐induced skin lesions; kidney function normalized and the patient became asymptomatic after 14 days of ganciclovir therapy. Nephrologists should consider the diagnosis of CMV disease in the febrile immunosuppressed patient with skin involvement. Skin biopsy must be considered as a useful and safe procedure in patients with a rash to obtain a prompt diagnosis and efficiently treat this immunocompromised population. 相似文献
998.
Zelinka T Timmers HJ Kozupa A Chen CC Carrasquillo JA Reynolds JC Ling A Eisenhofer G Lazúrová I Adams KT Whatley MA Widimsky J Pacak K 《Endocrine-related cancer》2008,15(1):311-323
We performed a retrospective analysis of 71 subjects with metastatic pheochromocytoma and paraganglioma (30 subjects with mutation of succinate dehydrogenase enzyme subunit B (SDHB) gene and 41 subjects without SDHB mutation). Sixty-nine percent presented with bone metastases (SDHB +/-: 77% vs 63%), 39% with liver metastases (SDHB +/-: 27% vs 47%), and 32% with lung metastases (SDHB +/-: 37% vs 29%). The most common sites of bone involvement were thoracic spine (80%; SDHB+/-: 83% vs 77%), lumbar spine (78%; SDHB +/-: 78% vs 75%), and pelvic and sacral bones (78%; SDHB +/-: 91% vs 65%, P=0.04). Subjects with SDHB mutation also showed significantly higher involvement of long bones (SDHB +/-: 78% vs 30%, P=0.007) than those without the mutation. The best overall sensitivity in detecting bone metastases demonstrated positron emission tomography (PET) with 6-[(18)F]-fluorodopamine ([(18)F]-FDA; 90%), followed by bone scintigraphy (82%), computed tomography or magnetic resonance imaging (CT/MRI; 78%), 2-[(18)F]-fluoro-2-deoxy-d-glucose ([(18)F]-FDG) PET (76%), and scintigraphy with [(123/131)I]-metaiodobenzylguanidine (71%). In subjects with SDHB mutation, imaging modalities with best sensitivities for detecting bone metastases were CT/MRI (96%), bone scintigraphy (95%), and [(18)F]-FDG PET (92%). In subjects without SDHB mutations, the modality with the best sensitivity for bone metastases was [(18)F]-FDA PET (100%). In conclusion, bone scintigraphy should be used in the staging of patients with malignant pheochromocytoma and paraganglioma, particularly in patients with SDHB mutations. As for PET imaging, [(18)F]-FDG PET is highly recommended in SDHB mutation patients, whereas [(18)F]-FDA PET is recommended in patients without the mutation. 相似文献
999.
Zunt JR Dezzutti CS Montano SM Thomas KK Alarcón JO Quijano E Courtois BN Sánchez JL Campos P Gotuzzo E Guenthner PC Lal RB Holmes KK 《The Journal of infectious diseases》2002,186(11):1669-1672
Human T cell lymphotropic virus type I (HTLV-I) is sexually transmitted. The purpose of this study was to determine the prevalence and risk factors for cervical shedding of HTLV-I DNA among Peruvian sex workers. HTLV tax DNA was detected in cervical specimens from 43 (68%) of 63 HTLV-I-infected sex workers and in samples obtained during 113 (52%) of 216 clinic visits between 1993 and 1997. Detection of HTLV DNA was associated with the presence of > or =30 polymorphonuclear cells (PMNs) within cervical mucus per 100x microscopic field (odds ratio [OR], 4.3, 95% confidence interval [CI], 1.8-10.1) and with the presence of cervical secretions (OR, 2.0; 95% CI 1.2-3.4). Hormonal contraceptive use (OR 1.7; 95% CI, 0.8-3.6) and concomitant cervical infection by Chlamydia trachomatis (OR, 1.5; 95% CI, 0.3-4.3) or Neisseria gonorrhoeae (OR, 1.1; 95% CI, 0.6-3.7) were not significantly associated with HTLV-I shedding. Our results suggest that cervicitis may increase cervical HTLV-I shedding and the sexual transmission of this virus. 相似文献
1000.
Astrid Rauh-Pfeiffer Uschi Handel Hans Demmelmair Wolfgang Peissner Mareile Niesser Diego Moretti Vanessa Martens Sheila Wiseman Judith Weichert Moritz Heene Markus Bühner Berthold Koletzko 《European journal of nutrition》2014,53(7):1445-1456